J. Bidwell et al., PARATHYROID-HORMONE REGULATES THE EXPRESSION OF RAT OSTEOBLAST AND OSTEOSARCOMA NUCLEAR MATRIX PROTEINS, Journal of cellular biochemistry, 63(3), 1996, pp. 374-383
Parathyroid hormone (PTH) alters osteoblast morphology. How these chan
ges in cell shape modify nuclear structure and ultimately gene express
ion is not known. Chronic exposure to rat PTH (1-34) [10 nM] attenuate
d the expression of 200, 190, and 160 kD proteins in the nuclear matri
x-intermediate filament subfraction of the rat osteosarcoma cells, ROS
17/2.8 [Bidwell et al. (1994b): Endocrinology 134:1738-1744]. Here, w
e determined that these same PTH-responsive proteins were expressed in
rat metaphyseal osteoblasts. We identified the 200 kD protein as a no
n-muscle myosin. Although the molecular weights, subcellular distribut
ion, and half-lives of the 190 and 160 kD proteins were similar to top
oisomerase II-alpha and -beta, nuclear matrix enzymes that mediate DNA
topology, the 190 and 160 kD proteins did not interact with topoisome
rase antibodies. Nevertheless, the expression of topoisomerase II-alph
a, and NuMA, a component of the nuclear core filaments, was also regul
ated by PTH in the osteosarcoma cells. The 190 kD protein was selectiv
ely expressed in bone cells as it was not observed in OK opossum kidne
y cells, H4 hepatoma cells, or NIH3T3 cells. PTH attenuated mRNA expre
ssion of the PTH receptor in our cell preparations. These results demo
nstrate that PTH selectively alters the expression of osteoblast membr
ane, cytoskeletal, and nucleoskeletal proteins. Topoisomerase II-alpha
, NuMA, and the 190 and 160 kD proteins may direct the nuclear PTH sig
nalling pathways to the target genes and play a structural role in ost
eoblast gene expression. (C) 1996 Wiley-Liss, Inc.